7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children
NCT03221504 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 221
Last updated 2018-03-20
Summary
The investigators aim to assess the effectiveness of a 7-day compared with a 10-day course of antibiotic treatment for febrile urinary tract infections (UTIs) in children. It is formulated a hypothesis that a 7-day course of antibiotic therapy is equally effective as a 10-day course of therapy and would entail a lower risk of adverse events and better compliance.
Conditions
- Urinary Tract Infections in Children
Interventions
- OTHER
-
Longer therapy duration
Patients will receive cefuroxime axetil orally. Treatment will involve the supply of cefuroxime axetil 30 mg/kg/d in two divided doses (in blinded bottles).
- OTHER
-
Shorter therapy duration
Patients will receive placebo orally (in blinded bottles). The volume of the placebo will be like cefuroxime syrup.
Sponsors & Collaborators
-
Medical University of Warsaw
lead OTHER
Principal Investigators
-
Malgorzata Pańczyk-Tomaszewska, Assistant Professor · Medical Univeristy of Warsaw
-
Maria Daniel, MD · Medical Univeristy of Warsaw
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Months
- Max Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2019-07-31
- Completion
- 2020-01-31
Countries
- Poland
Study Locations
More Related Trials
-
Reduction of Intravenous Antibiotics In Neonates
NCT03247920 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis
NCT06197269 ·Status: COMPLETED ·Phase: NA
-
Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer
NCT04637464 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Dosage Adjustment Strategies of Vancomycin in Children
NCT02694458 ·Status: COMPLETED ·Phase: NA
-
PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections
NCT00679835 ·Status: COMPLETED ·Phase: PHASE1
-
Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)
NCT01728376 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae
NCT02400268 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
NCT02334124 ·Status: COMPLETED ·Phase: NA
-
Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections
NCT02959957 ·Status: COMPLETED ·Phase: PHASE4
-
Use of a Loading Dose of Vancomycin in Pediatric Dosing
NCT01290237 ·Status: TERMINATED ·Phase: NA
-
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
NCT01019395 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Effectiveness of Intravenous v. Oral Antibiotic Therapy for Serious Bacterial Infections
NCT02311452 ·Status: COMPLETED
-
Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients
NCT03560440 ·Status: COMPLETED
-
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
NCT00136292 ·Status: COMPLETED ·Phase: PHASE1
-
Resistant Bacteria in Children in France
NCT06036628 ·Status: COMPLETED
-
Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis
NCT02344511 ·Status: WITHDRAWN ·Phase: PHASE3
-
Lung Concentrations of Ceftazidime in Patients With Ventilator-associated Pneumonia
NCT02837835 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI
NCT05826990 ·Status: RECRUITING ·Phase: PHASE2
-
Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)
NCT03643952 ·Status: COMPLETED ·Phase: PHASE2
-
Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
NCT06929702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
NCT04187755 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women
NCT05726318 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Colistin Based Antibiotic Therapy
NCT04764058 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
NCT02750761 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women
NCT01390623 ·Status: COMPLETED ·Phase: PHASE4